Aprocitentan Data Highlight Efficacy in Difficult-to-Control Hypertension

Two oral presentations at AHA Hypertension 2026 report aprocitentan efficacy in patients with obesity and across the cardiovascular-kidney-metabolic continuum, based on the PRECISION study.